GETI-B:STO
Getinge publ AB
253,20 SEK
arrow_upward
+1,44%(+3,60) 1D
9 հոկ, 17:29:44 GMT+2 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
249,60 SEK
High
255,90 SEK
Low
249,30 SEK
Mkt. cap
64,35 մլրդ
Avg. vol.
594,80 հզր
Volume
527,55 հզր
Dividend
1,88%
Quarterly dividend
1,19 SEK
Ex-dividend date
22 ապր, 2026 թ.
P/E ratio
25,79
52-wk high
255,90 SEK
52-wk low
175,90 SEK
EPS
9,82 SEK
Shares outstanding
254,15 մլն
No. of employees
12 հզր
Open
249,60 SEK
High
255,90 SEK
Low
249,30 SEK
Mkt. cap
64,35 մլրդ
Avg. vol.
594,80 հզր
Volume
527,55 հզր
Dividend
1,88%
Quarterly dividend
1,19 SEK
Ex-dividend date
22 ապր, 2026 թ.
P/E ratio
25,79
52-wk high
255,90 SEK
52-wk low
175,90 SEK
EPS
9,82 SEK
Shares outstanding
254,15 մլն
No. of employees
12 հզր
News stories
From web sources and news partners
TradingView
·
1 ժամ առաջ
Key facts: NASDAQ:SPCX to buy 800MHz spectrum; developing non‑GEO D2D
Yahoo Finance
·
10 ժամ առաջ
A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year
24/7 Wall St.
·
23 ժամ առաջ
Why "VOO and Chill" Lost Money for 8 Straight Years: What $100,000 in the S&P 500 Did From 2000 to 2008
MarketWatch
·
21 ժամ առաջ
S&P 500 at 10,000 or bust: New ETF offers investors all-or-nothing bet on the index
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB